Determinants of bone turnover markers in healthy premenopausal women

scientific article published on 10 May 2008

Determinants of bone turnover markers in healthy premenopausal women is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00223-008-9126-5
P698PubMed publication ID18470550

P50authorMaria Luisa BrandiQ29839820
P2093author name stringMaurizio Rossini
Sergio Ortolani
Sandro Giannini
Silvano Adami
Bruno Frediani
Gerolamo Bianchi
BONTURNO study group
Ombretta DiMunno
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)341-347
P577publication date2008-05-10
P1433published inCalcified Tissue InternationalQ5018771
P1476titleDeterminants of bone turnover markers in healthy premenopausal women
P478volume82

Reverse relations

cites work (P2860)
Q52647974Actions of pituitary hormones beyond traditional targets.
Q37184262Age-specific effects of estrogen receptors' polymorphisms on the bone traits in healthy fertile women: the BONTURNO study
Q39934392Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women.
Q34360040Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study
Q55002406Bone Turnover Status: Classification Model and Clinical Implications.
Q48169216Bone markers in polycystic ovary syndrome: A multicentre study.
Q51359928Bone metabolism in patients with anorexia nervosa and amenorrhoea.
Q50867809Bone remodelling is reduced by recovery from iron-deficiency anaemia in premenopausal women.
Q39517981Bone turnover marker reference intervals in young females.
Q38016073Bone turnover markers: use in osteoporosis
Q53388020Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women.
Q36491529Does estrogen play a role in response to adjuvant bone-targeted therapies?
Q35144713Effects of diosgenin on myometrial matrix metalloproteinase-2 and -9 activity and expression in ovariectomized rats
Q36242941Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer
Q34171858Establishing reference intervals for bone turnover markers in healthy postmenopausal women in a nonfasting state
Q36692024Establishing reference intervals for bone turnover markers in the healthy shanghai population and the relationship with bone mineral density in postmenopausal women
Q36056975Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic review
Q64075023FSH Beyond Fertility
Q43714450Further evidence that FSH causes bone loss independently of low estrogen
Q35025198Harmonised Australian Reference Intervals for Serum PINP and CTX in Adults
Q47116443Impact of Dietary Intake on Bone Turnover in Patients with Phenylalanine Hydroxylase Deficiency
Q58903546Long-Term Effects of Neridronate and its Discontinuation in Patients with Primary Hyperparathyroidism
Q37823835Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
Q33572610National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges
Q38017609Osteoporosis in young adults: pathophysiology, diagnosis, and management.
Q38104738Osteoporosis treatment: why ibandronic acid?
Q37048294Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
Q90450569Reference Intervals for Bone Turnover Markers in Korean Healthy Women
Q34623146Reference intervals for serum osteocalcin concentrations in adult men and women from the study of health in Pomerania
Q45155246Reference intervals of bone turnover markers determined by using their curve-fitting valley for adult females in China
Q42910767Serum osteocalcin is related to abdominal obesity in Korean obese and overweight men
Q38921875The Utility of Biomarkers in Osteoporosis Management.

Search more.